It was reported that on (b)(6) 2024, a mitraclip procedure was performed to treat degenerative mitral regurgitation (mr) with a grade of 3 and flail.Two clips were implanted, reducing mr to a grade of 1.On (b)(6) 2024, the patient returned to the hospital due to dyspnea.On (b)(6) 2024, imagining showed that one of the implanted clips had detached from anterior leaflet and remained attached to the posterior (single leaflet device attachment/slda), causing mr to increase to 4.It was also observed endocarditis growth on both implanted mitraclips.The patient was experiencing fatigue and had a fever due to the endocarditis.Iv antibiotics were given to the patient to treatment.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the cause of the reported slda and endocarditis were unable to be determined.The reported worsening mr was a cascading event of the reported slda.The reported dyspnea was a cascading event of the reported worsening mr.The reported fatigue and fever were cascading effects of the reported endocarditis.The reported patient effects of dyspnea, endocarditis, fever, and mitral regurgitation, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported hospitalization and medication required were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|